![](/fileadmin/_processed_/9/6/csm_Togaspic_c2e342e85d.png)
The 2022 European “Council Recommendation on strengthening prevention through early detection: a new EU approach on cancer screening” is recommending implementation of three new cancer screening programs, including for gastric cancer, in the European Union (EU).
The TOGAS project* (“Towards gastric cancer screening implementation in the European Union”) brings together 20 partners from 14 European countries to address effective implementation of gastric cancer screening across the EU.
The purpose of this conference is to inform participants on the current evidence related to gastric cancer prevention as well as to gather feedback from EU Member States on the needs and potential barriers for streamlining gastric cancer screening. We encourage policymakers, screening experts, epidemiologists, medical specialists, as well as patient representatives, to participate in person and share their insights, experiences, and expertise. We look forward to fruitful discussions and collaborations that will undoubtedly arise from this gathering. Together, let us work towards improving gastric cancer prevention and screening practices across Europe, with the ultimate aim of reducing the burden of this devastating disease.
We invite representatives from the Member States, national screening experts and patient advocates to participate in the Conference “Towards gastric cancer screening implementation in the European Union” to be held on September 7, 2023 in the Flanders Meeting & Convention Center Antwerp, Belgium. The conference will also feature live video streaming.
Date and place:
September 7, 2023
Flanders Meeting & Convention Center, Antwerp, Belgium and on‐line
Registration:
The registration for in-person participation is already closed, but you can still register for the conference online. Please register here to receive an access link to the online conference.
Participants:
‐ EU country representatives (ministries, national cancer institutes)
‐ European Council & JRC representatives
‐ Cancer screening specialists
‐ Project consortia members (TOGAS, EUROHELICAN, AIDA, PRAISE‐U, SOLACE)
‐ Researchers and opinion leaders involved in gastric cancer prevention
‐ Patient advocates